메뉴 건너뛰기
Medical Hypotheses
Volumn 72, Issue 2, 2009, Pages 227-228
Metformin for the prevention of androgen deprivation induced metabolic syndrome, obesity and type 2 diabetes
Author keywords

[No Author keywords available]
Indexed keywords

ANDROGEN; METFORMIN; NEUROLEPTIC AGENT;
EID: 57749199485     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2008.09.024     Document Type: Letter
Times cited : (5)
References (6)
  • 1
    • 33748474608 scopus 로고    scopus 로고
    • Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy
    • Braga-Basaria M., Dobs A.S., Muller D.C., Carducci M.A., John M., Egan J., et al. Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy. J Clin Oncol 24 (2006) 3979-3983
    • (2006) J Clin Oncol , vol.24 , pp. 3979-3983
    • Braga-Basaria, M.1    Dobs, A.S.2    Muller, D.C.3    Carducci, M.A.4    John, M.5    Egan, J.6
  • 2
    • 52949100543 scopus 로고    scopus 로고
    • Androgen deprivation therapy, insulin resistance and cardiovascular mortality: an incovenient truth
    • Basaria S. Androgen deprivation therapy, insulin resistance and cardiovascular mortality: an incovenient truth. J Androl (2008)
    • (2008) J Androl
    • Basaria, S.1
  • 3
    • 42449102198 scopus 로고    scopus 로고
    • Metformin addition attenuates olanzapine-induced weight gain in drug-naive first episode schizophrenia patients: a double-blind, placebo controlled study
    • Wu R.R., Zhao J.P., Guo X.F., He Y.Q., Fang M.S., Guo W.B., et al. Metformin addition attenuates olanzapine-induced weight gain in drug-naive first episode schizophrenia patients: a double-blind, placebo controlled study. Am J Psychiat 165 (2008) 352-358
    • (2008) Am J Psychiat , vol.165 , pp. 352-358
    • Wu, R.R.1    Zhao, J.P.2    Guo, X.F.3    He, Y.Q.4    Fang, M.S.5    Guo, W.B.6
  • 4
    • 33846294762 scopus 로고    scopus 로고
    • A randomized, double-blind placebo-controlled trial of metformin treatment of weight gain associated with the initiation of atypical antipsychotic therapy in children and adolescents
    • Klein D.J., Cottingham E.M., Sorter M., Barton B.A., and Morrison J.A. A randomized, double-blind placebo-controlled trial of metformin treatment of weight gain associated with the initiation of atypical antipsychotic therapy in children and adolescents. Am J Psychiat 163 (2006) 2072-2079
    • (2006) Am J Psychiat , vol.163 , pp. 2072-2079
    • Klein, D.J.1    Cottingham, E.M.2    Sorter, M.3    Barton, B.A.4    Morrison, J.A.5
  • 5
    • 44649106470 scopus 로고    scopus 로고
    • Role of metformin for weight management in patients without type 2 diabetes
    • Desilets A.R., Dhakal-Karki S., and Dunican K.C. Role of metformin for weight management in patients without type 2 diabetes. Ann Pharmacother 42 (2008) 817-826
    • (2008) Ann Pharmacother , vol.42 , pp. 817-826
    • Desilets, A.R.1    Dhakal-Karki, S.2    Dunican, K.C.3
  • 6
    • 34047131663 scopus 로고    scopus 로고
    • DDK research group. Factors associated with diabetes onset during metformin versus placebo therapy in the diabetes prevention program
    • Lachin J.M., Christophi C.A., Edelstein S.L., Ehrmann D.A., Hamman R.F., Kahn S.E., et al. DDK research group. Factors associated with diabetes onset during metformin versus placebo therapy in the diabetes prevention program. Diabetes 56 (2007) 1153-1159
    • (2007) Diabetes , vol.56 , pp. 1153-1159
    • Lachin, J.M.1    Christophi, C.A.2    Edelstein, S.L.3    Ehrmann, D.A.4    Hamman, R.F.5    Kahn, S.E.6

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.